Yingxue Jin

Prof. Yingxue Jin

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
WMWei Ma
Wei Ma
HZHuanli Zhang
Huanli Zhang
SLShuying Li
Shuying Li
ZWZhiqiang Wang
Zhiqiang Wang
XWXiaodan Wu
Xiaodan Wu
YJYingxue Jin
Yingxue Jin

28 April 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
ZSZhongping Su
Zhongping Su
HXHaiying Xu
Haiying Xu
YZYing Zhang
Ying Zhang
HZHuanli Zhang
Huanli Zhang
HZHui Zhang
Hui Zhang
YJYingxue Jin
Yingxue Jin
Immune checkpoint blockade (ICB) is a kind of promising anti-tumor immunotherapy that can block the negative immune regulatory pathways using a particular antibody. Weak immunogenicity in most patients is a key obstacle to ICB therapy. Photodynamic therapy (PDT) is a non-invasive treatment that can enhance the immunogenicity of the host and realize systemic anti-tumor immunotherapy; yet tumor microenvironment hypoxia and glutathione overexpression severely restrict the PDT effect. To overcome the above issues, we design a combination therapy based on PDT and ICB. We prepared red carbon dot (RCD)-doped Cu-metal–organic framework nanoparticles (Cu-MOF@RCD) as smart nano-reactors because their tumor microenvironment and near-infrared light responsive property can decompose tumor endogenous H2O2 through Fenton-like reactions. Cu-MOF@RCD also shows clear near-infrared photothermal therapy (PTT) effect and has an ability to deplete glutathione (DG), which together enhances decomposition of cellular H2O2 and amplifies reactive oxygen species (ROS) levels in cells, thus leading to enhanced PDT and chemodynamic therapy (CDT) effect. Moreover, programmed cell death-ligand 1 antibody (anti-PD-L1) is used together to enable combination therapy, as Cu-MOF@RCD can significantly enhance host immunogenicity. In summary, the combination of Cu-MOF@RCD with anti-PD-L1 antibody exerts a synergistic PDT/PTT/CDT/DG/ICB therapy and can be used to eradicate the primary tumors and inhibit the growth of untreated distant tumors and tumor metastasis.

14 March 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
XQXiang Qin
Xiang Qin
HZHongyue Zhang
Hongyue Zhang
ZWZhiqiang Wang
Zhiqiang Wang
YJYingxue Jin
Yingxue Jin
Photodynamic therapy (PDT) is an increasingly recognized alternative to treat various cancers in clinical practice. Most second-generation photosensitizers (PS) are hydrophobic and have poor targeting selectivity, which limit their efficacy for PDT. In this paper, graphene oxide (GO) coupled with magnetic Fe3O4 nanoparticles and chitosan (CS) (MCGO) was prepared by a one-pot solvothermal method and used as a nanocarrier for loading the new photosensitizer HNPa (λmax = 698 nm), which was first synthesized by our group, and was considered as a good water-soluble drug and an excellent tissue-penetrating agent due to its strong absorption at 698 nm (near-infrared region). The synthesized composite (MCGO–HNPa) showed high stability, good water solubility and biocompatibility, expected magnetic targetability, and good photostability for PDT even in low concentrations. Our research reveals that MCGO nanomaterials can promote the production and release of singlet oxygen (ΦΔ = 62.9%) when compared with free HNPa. In addition, the in vitro cell uptake experiments suggested that the MCGO nanomaterials can accelerate the penetration of HNPa drugs into the tumor cell nucleus and that the drug release behavior is pH-sensitive. The MTT assay results against human hepatoma cell lines HepG-2 clearly show that the MCGO–HNPa composite can effectively result in cell damage and apoptotic cell death under light, and that the nanocomposite can improve the PDT antitumor effect of PS agents with negligible dark toxicity. Meanwhile, the research on the photoreaction mechanism reveals that Type I and Type II photodynamic reactions can occur simultaneously in this PDT process, and their relative contributions depend on the type and dose of the photosensitizer. Type II has a greater effect on PDT than Type I, especially for a higher HNPa photosensitizer dose. All the results reveal the promising application of the presented novel strategy.

15 September 2022 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
QXQing Xia
Qing Xia
YZYing Zhang
Ying Zhang
HZHui Zhang
Hui Zhang
XZXiong Zhang
Xiong Zhang
XWXiaodan Wu
Xiaodan Wu
YJYingxue Jin
Yingxue Jin
Copper nanocrystalline-doped folic acid-based super carbon dots (FA-CDs@Cu x ) were prepared to realize an enhanced antitumor effect in response to tumor microenvironment stimuli.

15 August 2016 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
JCJianjun Cheng
Jianjun Cheng
GTGuanghui Tan
Guanghui Tan
WLWenting Li
Wenting Li
HZHongyue Zhang
Hongyue Zhang
WXWu Xiaodan
Wu Xiaodan
YJYingxue Jin
Yingxue Jin
Chitosan assisted magneto-fluorescence nanoparticle Fe3O4@SiO2@CS@PPA is a potential photosensitizer for simultaneous PDT and medical fluorescence imaging.

23 March 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SLSiqi Li
Siqi Li
HZHui Zhang
Hui Zhang
YBYujun Bao
Yujun Bao
HZHuanli Zhang
Huanli Zhang
JWJingchun Wang
Jingchun Wang
YJYingxue Jin
Yingxue Jin